Limits to causal inference based on mendelian randomization: A comparison with randomized controlled trials

American Journal of Epidemiology

Volumn 163, Issue 5, 2006, Pages 397-403

  Nitsch, Dorothea ^a   Molokhia, Mariam ^a   Smeeth, Liam ^a   DeStavola, Bianca L ^a   Whittaker, John C ^a   Leon, David A ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Causality; Epidemiologic methods; Genetics; Random allocation; Randomized controlled trials

Indexed keywords

GENE PRODUCT;

EPIDEMIOLOGY;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENETIC VARIABILITY; HEALTH PRACTITIONER; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; EPIDEMIOLOGY; HUMAN; METHODOLOGY; RANDOMIZATION; REVIEW;

CAUSALITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); EPIDEMIOLOGIC METHODS; HUMANS; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS;

EID: 33645084282     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj062     Document Type: Article

References (48)

1. Kleinen J, Gotzsche P, Kunz RA, et al. So what's so special about randomization? In: Maynard A, Chalmers I, eds. Non-random reflections on health services research. On the 25th anniversary of Archie Cochrane's Effectiveness and Efficiency. London, United Kingdom: BMJ Publishing Group, 1997: 93-106.
2. Davey Smith G, Ebrahim S. Mendelian randomization: prospects, potentials and limitations. Int J Epidemiol 2004;33:30-42.
3. Thomas DC, Conti DV. Commentary: the concept of "Mendelian randomization." Int J Epidemiol 2004;33:21-5.
4. Tobin MD, Minelli C, Burton PR, et al. Commentary: development of Mendelian randomization: from hypothesis test to "Mendelian deconfounding." Int J Epidemiol 2004;33:26-9.
5. Katan MB. Commentary: Mendelian randomization, 18 years on. Int J Epidemiol 2004;33:10-11.
6. Keavney B. Commentary: Katan's remarkable foresight: genes and causality 18 years on. Int J Epidemiol 2004;33:11-14.
7. Khoury MJ, Millikan R, Little J, et al. The emergence of epidemiology in the genomics age. Int J Epidemiol 2004;33:936-44.
8. Casas JP, Bautista LE, Smeeth L, et al. Homocysteine and stroke: evidence on a causal link from Mendelian randomisation. Lancet 2005;365:224-32.
9. Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005;330:1076-9.
10. Davey Smith G, Ebrahim S. "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
11. Little J, Khoury MJ. Mendelian randomisation: a new spin or real progress? Lancet 2003;362:930-1.
12. Clayton D, McKeigue P. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-60.
13. Greenland S. Randomization, statistics and causal inference. Epidemiology 1990;1:421-9.
14. Moher D, Schulz KF, Altman DG, et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Clin Oral Investig 2003;7:2-7.
15. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94.
16. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000;29:722-9.
17. Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics 2002;58:21-9.
18. Pearl J. Causality: models, reasoning and inference. Cambridge: Cambridge University Press, 2000.
19. Cox DR, Wermuth N. Causality: a statistical view. Int Stat Rev 2004;72:285-305.
20. Buzas JS, Stefanski LA. Instrumental variable estimation in generalized linear measurement error models. J Am Stat Assoc 1996;91:999-1006.
21. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;91:444-55.
22. Greenland S, Brumback B. An overview of relations among causal modelling methods. Int J Epidemiol 2002;31:1030-7.
23. McIntosh MW. Instrumental variables when evaluating screening trials: estimating the benefit of detecting cancer by screening. Stat Med 1999;18:2775-94.
24. Minelli C, Thompson JR, Tobin MD, et al. An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization. Am J Epidemiol 2004;160:445-52.
25. Katan MB. Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1986;1:507-8.
26. Collins R, Armitage J, Parish S, et al. MRC/BHF Heart Protection Study. (Letter). Lancet 2002;360:1783-4.
27. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604.
28. Whittaker JC, Morris AP. Family-based tests of association and/or linkage. Ann Hum Genet 2001;65:407-19.
29. Schaid DJ, Sommer SS. Genotype relative risks: methods for design and analysis of candidate-gene association studies. Am J Hum Genet 1993;53:1114-26.
30. Hoggart C, Parra EJ, Shriver MD, et al. Control of confounding of genetic associations in stratified populations. Am J Hum Genet 2003;72:1492-504.
31. Morris AP, Whittaker JC, Balding DJ. Fine-scale mapping of disease loci via shattered coalescent modeling of genealogies. Am J Hum Genet 2002;70:686-707.
32. Pritchard JK, Przeworski M. Linkage disequilibrium in humans: models and data. Am J Hum Genet 2001;69:1-14.
33. Jousilahti P, Salomaa V. Fibrinogen, social position, and "Mendelian randomisation." (Letter). J Epidemiol Community Health 2004;58:883.
34. Hartman JL, Garvik B, Hartwell L. Principles for the buffering of genetic variation. Science 2001;291:1001-4.
35. Siegal ML, Bergman A. Waddington's canalization revisited: developmental stability and evolution. Proc Natl Acad Sci U S A 2002;99:10528-32.
36. Bergman A, Siegal ML. Evolutionary capacitance as a general feature of complex gene networks. Nature 2003;424:549-52.
37. Nadeau JH. Genetics: modifying the message. Science 2003;301:927-8.
38. Scriver CR, Waters PJ. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet 1999;15:267-72.
39. Bystrykh L, Weersing E, Dontje B, et al. Uncovering regulatory pathways that affect hematopoietic stem cell function using "genetical genomics." Nat Genet 2005;37:225-32.
40. Chesler EJ, Lu L, Shou S, et al. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet 2005;37:233-42.
41. Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures
42. Dunning AM, Dowsett M, Healey CS, et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2004;96:936-45.
43. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
44. Colhoun H, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex diseases. Lancet 2003;361:865-72.
45. Morrison N. Commentary: vitamin D receptor polymorphism and bone mineral density: effect size in Caucasians means detection is uncertain in small studies. Int J Epidemiol 2004;33:989-94.
46. Hirschhorn JN, Lohmueller K, Byrne E, et al. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
47. Greenland S. Multiple bias modeling for analysis of observational data. J R Stat Soc A 2005;168:1-25.